Zhang Youcai, Shi Zhaohong, Deng Changsheng, Zhu Youqing, Zhou Yan
Department of Gasteroenterology, Zhongnan Hospital, Wuhan University, Wuhan Hospital, Wuhan, China.
Zhonghua Nei Ke Za Zhi. 2002 Nov;41(11):746-9.
In this study, we analyzed the association genetic polymorphisms of N-acetyltransferase 1 (NAT1) with genetic susceptibility to sporadic colorectal adenocarcinoma (SCRAC).
All subjects are unrelated Han people in Hubei province of China. Using multiple PCR and PCR-RFLP, we studied the genotypes and genetic polymorphisms of the NAT1 gene of 101 healthy controls and 104 SCRAC patients.
(1) The frequency of NAT1 * 10 was significantly higher among the SCRAC when compared with the controls (P < 0.05, OR = 1.91, 95% CI = 1.1 - 3.4), and among the elder SCRAC when compared to the controls (P < 0.01, OR = 2.91, 95% CI = 1.48 - 5.90), (2) The frequency of NAT1 * 10 relative to SCRAC tumor location as follow: proximal SCRAC (44.4%), distal SCRAC (41.6%), all the difference were not statistically significant relative to the controls; The frequency of NAT1 * 10 genotype was significantly higher in stage II cases (P < 0.05, OR = 2.48, 95% CI = 1.18 - 5.20) and stage III and IV cases (P < 0.05, OR = 3.04, 95% CI = 1.28 - 7.20) when compared with the controls.
NAT1 * 10 has increased risk of SCRAC and significantly related to the later stage tumors, is not significantly related to the tumor location, whether the elder individuals with NAT1 * 10 have increased risk of SCRAC needs further study.
本研究分析了N - 乙酰基转移酶1(NAT1)基因多态性与散发性结直肠癌(SCRAC)遗传易感性的关系。
所有受试者均为中国湖北省无血缘关系的汉族人。采用多重PCR和PCR - RFLP技术,研究了101例健康对照者和104例SCRAC患者NAT1基因的基因型和基因多态性。
(1)与对照组相比,SCRAC患者中NAT1 * 10的频率显著更高(P < 0.05,OR = 1.91,95% CI = [1.1, 3.4]),与对照组相比,老年SCRAC患者中该频率更高(P < 0.01,OR = 2.91,95% CI = [1.48, 5.90]);(2)NAT1 * 10相对于SCRAC肿瘤位置的频率如下:近端SCRAC(44.4%),远端SCRAC(41.6%),与对照组相比所有差异均无统计学意义;与对照组相比,II期病例(P < 0.05,OR = 2.48,95% CI = [1.18, 5.20])以及III期和IV期病例(P < 0.05,OR = 3.04,95% CI = [1.28, 7.20])中NAT1 * 10基因型的频率显著更高。
NAT1 * 10增加了SCRAC的发病风险,且与晚期肿瘤显著相关,与肿瘤位置无显著相关性,携带NAT1 * 10的老年个体SCRAC发病风险是否增加有待进一步研究。